• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
72,388.02 -1,195.20
( -1.62%)
Global Indices
Nasdaq
45,202.56 -778.56
(-1.69%)
Dow Jones
6,394.42 -103.74
(-1.60%)
Hang Seng
51,747.70 -1,625.37
(-3.05%)
Nikkei 225
9,959.27 -12.90
(-0.13%)
Forex
USD-INR
94.09 0.23
(0.24%)
EUR-INR
108.64 -0.12
(-0.11%)
GBP-INR
125.57 -0.09
(-0.07%)
JPY-INR
0.59 0.00
(-0.07%)

EQUITY - MARKET SCREENER

Neuland Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
524558
INE794A01010
1255.9414887
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
NEULANDLAB
86.86
15488.5
EPS(TTM)
Face Value()
Div & Yield %
138.98
10
0.1
 
( Cr)
ParticularsDec 2025 ( Cr)Sep 2025 ( Cr)Jun 2025 ( Cr)
Gross Sales439.71514.27292.75
Other Operating Income0.000.000.00
Other Income 8.051.807.86
Total Income447.76516.07300.61
Total Expenditure 362.78359.15258.46
PBIDT84.98156.9242.15
Interest 6.795.344.58
PBDT78.19151.5837.57
Depreciation23.9222.5420.19
Tax15.2132.514.37
Fringe Benefit Tax0.000.000.00
Deferred Tax-1.350.07-0.70
Reported Profit After Tax40.4296.4613.71
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item40.4296.4613.71
EPS (Unit Curr.)31.5075.1810.68
EPS (Adj) (Unit Curr.)31.5075.1810.68
Calculated EPS (Unit Curr.)31.3374.7710.63
Calculated EPS (Adj) (Unit Curr.)31.3374.7710.63
Calculated EPS (Ann.) (Unit Curr.)125.31299.0942.50
Calculated EPS (Adj) (Ann.) (Unit Curr.)125.31299.0942.50
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity12.9012.9012.90
Reserve & Surplus0.000.000.00
Face Value10.0010.0010.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)19.3330.5114.40
PBDTM(%)17.7829.4712.83
PATM(%)9.1918.764.68